Mounjaro and Ozempic are once-weekly weight loss injections used in Malaysia under medical supervision. Mounjaro often leads to greater weight loss because it works on two appetite hormones, while Ozempic has been used longer and has proven heart benefits. The right choice depends on BMI, health risks, side effects, and doctor guidance.
What Are Mounjaro and Ozempic?

Mounjaro (tirzepatide) and Ozempic (semaglutide) are prescription injectable medications first developed for people with type 2 diabetes. Today, many doctors in Malaysia also prescribe them for medical weight loss, even in people without diabetes, when clinically appropriate.
Both are taken once a week as a small injection under the skin. They help reduce hunger, control cravings, and improve how your body uses insulin. When combined with healthier eating and regular movement, they can support safe, long-term weight loss.
Core Medical Differences at a Glance
| Feature | Mounjaro | Ozempic |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Drug class | Dual GIP + GLP-1 receptor agonist | GLP-1 receptor agonist |
| Average weight loss | ~15–22% | ~10–15% |
| Appetite suppression | Very strong | Strong |
| HbA1c reduction | Significant | Significant |
| Cardiovascular benefit | Still being studied | Established benefit |
| Long-term safety data | Newer | Longer track record |
| Tolerability | Moderate | Generally easier |
Ingredients, Doses & Injection Pens

Mounjaro (Tirzepatide)
Dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Single-use prefilled pen
Injected once weekly
Ozempic (Semaglutide)
Dose strengths: 0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg
Multi-dose pen
Injected once weekly
👉 Both medications require dose escalation, meaning you start low and slowly increase the dose to reduce side effects.
How Mounjaro and Ozempic Help You Lose Weight
Ozempic (GLP-1 Only)
Sends signals to the brain that reduce hunger
Slows stomach emptying so you feel full longer
Improves insulin sensitivity
Reduces food cravings and portion size
Mounjaro (GIP + GLP-1)
Does everything Ozempic does, plus
Activates GIP receptors that improve fat metabolism
Produces stronger appetite suppression
Leads to greater waist circumference reduction
Improves insulin resistance more powerfully
Because Mounjaro works on two hormonal pathways instead of one, studies show it often results in greater overall weight loss.
Weight Loss Results: What You Can Realistically Expect
Average Weight Loss from Clinical Studies
Mounjaro: ~15–22% body weight over ~72 weeks
Ozempic: ~10–15% body weight over ~52 weeks
Your personal results depend on:
Starting BMI and obesity class
Dose reached and how long you stay on treatment
Diet quality and protein intake
Physical activity level
Consistency and follow-up care
Weight loss is gradual, not overnight. Most people start noticing visible changes after 8–12 weeks.
Treatment Protocol & Dose Adjustment
Both medications follow a similar medical protocol:
Start at the lowest dose
Increase dose every 4 weeks
Monitor side effects
Adjust based on response
Doctors also monitor:
Body weight and waist circumference
HbA1c and blood sugar levels
Gastrointestinal tolerance
Weight plateaus or excessive appetite suppression
This is why these injections should never be used without medical supervision.
Benefits Beyond Weight Loss
Reduced visceral (organ) fat
Improved insulin sensitivity
Lower HbA1c levels
Reduced food noise and cravings
Better metabolic health
Waistline reduction
Ozempic also has strong evidence for cardiovascular risk reduction in patients with diabetes.
Side Effects & Medical Risks
Common Side Effects
Nausea
Vomiting
Diarrhea
Constipation
Bloating
Fatigue during dose increases
Less Common but Important
Gallstones from rapid weight loss
Dehydration if fluid intake is poor
Reduced protein intake due to low appetite
Rare but Serious Contraindications
Medullary thyroid cancer history
MEN2 syndrome
Severe gastroparesis
Pregnancy or breastfeeding
Most side effects improve once your body adjusts to the dose.
Downtime & Daily Life
No procedure downtime
Normal daily activities can continue
Side effects mainly occur during early weeks or dose changes
Adequate hydration and protein intake are essential
Who Is Suitable for These Injections?
You may be suitable if:
BMI ≥ 27 with metabolic risk factors
BMI ≥ 30 (obesity)
Insulin resistance or type 2 diabetes
Lifestyle-only weight loss has failed
You may not be suitable if you have certain endocrine cancers or severe digestive conditions.
👉 A doctor’s assessment is required before starting.
Mounjaro vs Ozempic: Which One Should You Choose?
Choose Mounjaro if:
You need significant weight loss
You have insulin resistance
Previous GLP-1 treatment wasn’t enough
You tolerate strong appetite suppression
Choose Ozempic if:
You prefer a medication with longer safety data
You want steadier, slower weight loss
You have cardiovascular risk factors
Cost and availability matter
There is no “better” option for everyone.
Can You Switch Between Mounjaro and Ozempic?
Yes, switching is possible, but:
Doses are not equivalent
Medications should not overlap
Medical supervision is required
Titration must be adjusted carefully
Long-Term Use, Aftercare & Maintenance
Long-term success depends on:
Regular medical follow-ups
Adequate protein intake
Resistance or strength training
Good sleep and stress management
Stopping suddenly may lead to weight regain without lifestyle changes or maintenance dosing.
Frequently Asked Questions (FAQ)
Is Mounjaro approved for weight loss in Malaysia?
It is approved for diabetes. Weight loss use is off-label but commonly prescribed by doctors.
Is Ozempic safer than Mounjaro?
Ozempic has longer real-world safety data. Both are safe when used correctly.
Which one causes less nausea?
Ozempic is usually better tolerated, but individual response varies.
Do I need diabetes to use these injections?
No. Many people use them for obesity management without diabetes.
How fast will I lose weight?
Most people see changes within 2–3 months.
Will I gain weight back if I stop?
Weight regain can happen without lifestyle changes or maintenance treatment.
References
Head-to-Head Weight Loss Comparison Study – Real-world evidence showing tirzepatide (Mounjaro) users were more likely to achieve significant weight loss than semaglutide (Ozempic) users:
👉 https://www.healthline.com/health-news/mounjaro-better-ozempic-weight-loss-**study-finds** HealthlineMeta-Analysis of Tirzepatide vs Semaglutide – Systematic review showing tirzepatide demonstrated superior weight reduction compared to semaglutide in overweight and obese adults:
👉 https://pubmed.ncbi.nlm.nih.gov/40666599/ pubmed.ncbi.nlm.nih.gov